Medpace Holdings, Inc. (MEDP) is in Healthcare, Diagnostics & Research, based in United States, listed on NasdaqGS. Market cap 16.82B USD. 52-week range 373.00 to 677.90 USD. Trailing P/E 35.4. Data as of 2026-10-09.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project ...